This document provides an expert consensus update on the concomitant use of proton pump inhibitors and thienopyridines to reduce gastrointestinal risks.
Guides PPI co-therapy decisions with thienopyridines to reduce GI risk; extends prior consensus with updated evidence synthesis.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: